Kelly was first diagnosed with Juvenile Idiopathic Arthritis (JIA) at the early age of two. At the time of her diagnosis in 1982, options for treatment were extremely limited. As a result, Kelly’s mobility has become exceedingly restricted, requiring a walker or wheelchair at home...
The foundations of a rheumatology researcher… As a young child, Anna Helena Jonsson, MD, PhD, was close friends with a girl who had juvenile idiopathic arthritis. As she grew up, this was not in the forefront of her thoughts but once in college this early experience...
ANRF Alumni, Dr. Betty Tsao, Dr. Jian Zhao and their colleagues identified a genetic risk factor for autoimmune disease found in an under-explored genomic region Last year, Nature Genetics published findings by a team of ANRF Alumni at the Medical University of South Carolina (MUSC) uncovering a...
Dr. Judith Ashouri-Sinha has a personal connection to Rheumatoid Arthritis (RA) that has been the driving force behind her motivation to work in research. As a child, she experienced the impact of RA in her own home, witnessing the struggles her mother endured as a...
USC researchers’ unique approaches are making a difference for those with autoimmune diseases, which affect some 50 million Americans. Approximately 50 million Americans suffer from autoimmune disease, according to the American Autoimmune Related Diseases Association. This includes the millions suffering from rheumatoid arthritis and lupus. Researchers...
Chelsie Calvert was diagnosed with Juvenile Rheumatoid Arthritis (JRA) in 1992 at a mere 14 months old. She has spent a lifetime not allowing the diagnosis of JRA to define her. Rather, she has worked and continues to work hard to rise above it, carving...
Gale "Morrie" Granger (1937-2018), whose groundbreaking discoveries shaped modern therapeutic modalities in Arthritis, Immunology and Cancer, left us earlier this year at the age of 81. Morrie’s commitment to raising the next generation of thinkers was unparalleled, and his selfless dedication to ANRF remains our...
ANRF Scientific Advisory Board Chairman, Dr. Carl Ware and his team at Sanford Burnham Prebys Medical Discovery Institute (SBP), announced that the first healthy subject has been dosed in a Phase 1 clinical trial evaluating LY3361237. LY3361237 is a biologic that inhibits inflammation by activating...
Peter A. Nigrovic, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician at Brigham and Women’s Hospital. He is a practicing adult and pediatric rheumatologist and director of the Center for Adults with Pediatric Rheumatic Illness (CAPRI) at the Brigham and...
Held in Chicago, IL, the autumn Autoimmunology Conference 2018 was an opportunity for ANRF to foster one of their important objectives – the sponsorship and support of young innovative researchers. For more than four decades this conference has provided a collaborative platform that allows experienced...